Clinical trial
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of a Post-coital Intravaginal Gel of PKB171 in Couples With Mild Male Factor Infertility.
NCT07669584 is registered in ClinicalTrials.gov with Prokrea BCN, S.L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of a Post-coital Intravaginal Gel of PKB171 in Couples With Mild Male Factor Infertility.
- Lead sponsor
- Prokrea BCN, S.L.
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- October 28, 2025
- Completion date
- October 28, 2027
- Enrollment
- 732 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
infertility due to azoospermia